CDH2 and gastric cancer: Consistently, the activation of the PI3K/AKT pathway by its specific activator (740 Y-P, 20μM) markedly attenuated the expression of E-cadherin and increased the expression of N-cadherin and Vimentin in GC cells with AGT knockdown (Figure 7G,H).